Skip to content

CATHCOAT: A specialized coating on intravascular catheters designed to reduce the risk of infection

CATHCOAT: LipoCoat-coated Eline CVC catheters - CATHCOAT: LipoCoat-coated Eline CVC catheters

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON61416
Enrollment
25
Registered
2026-01-21
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU patients with an indication for a CVC line ICU patients that need a CVC line in an acute situation.

Interventions

The coated CVC (16 or 20cm double lumen (7Fr and 8Fr)) will be inserted ultrasound guided into the left or right internal jugular vein or subclavian vein and left in place for a maximum of 29 days aft

Sponsors

Lipo Coat onderdeel van Universiteit Twente
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Adult (=18 years) ICU patients with a CVC indication for at least 5 days.Written informed consent has been obtained from a competent patient.                                An intensivist who is not involved in the patient's inclusion, admission, or initial treatment will assess the patient's decision-making capacity using a predefined step-by-step protocol (see Appendix 5 CIP). If there is any doubt regarding the patient's decision-making capacity, an independent surgeon (RHG) who is not involved in the patient's treatment will be asked to perform an additional assessment

Exclusion criteria

Exclusion criteria: < 18 years, Patients with severe coagulation disorders (e.g. thrombocyte count <50) CVC indication for less than 5 days.Patiënts with active infection at the insertion site.Patiënts with vascular injury near the insertion site.The patient or his legal representative has not been given consent to continue the study.Patients who are pregnant or breastfeeding.Patients that are incapacitatedOther contra-indications for CVC-use

Design outcomes

Primary

MeasureTime frame
Safety of the coated CVCs in 25 ICU patients

Secondary

MeasureTime frame
Usability of the coated CVC. Analysis of bioburden on used CVC ex vivo as an indication for clinical antifouling performance. Characterization of used CVC using laboratory analysis techniques.

Countries

Netherlands

Contacts

Public ContactM.J.G Damhuis

Medisch Spectrum Twente (MST)

Michiel.damhuis@mst.nl31618403994

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 10, 2026